| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.083 | 0.008 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.009 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |